Full-Time

Head of Commercial Capability & Training

Posted on 8/18/2026

Biote

Biote

201-500 employees

Clinically validated hormone optimization and treatment

No salary listed

Irving, TX, USA

In Person

Bachelor's

Category
Business & Strategy (1)

Get referred to Biote

See people who can refer or advise you

Requirements
  • A bachelor's degree is required.
  • At least 12 years of commercial leadership experience in life sciences, diagnostics, biotechnology, medical device, or pharmaceutical industries is required.
  • Significant experience leading Commercial Training, Sales Enablement, Commercial Learning, or Commercial Capability functions is required.
  • Demonstrated success partnering with executive leadership and national sales organizations is required.
  • Demonstrated expertise in adult learning principles and designing scalable, high-impact commercial learning programs is required.
  • Experience designing scalable onboarding, leadership development, certification, and commercial learning programs is required.
  • Experience building commercial competency models, coaching frameworks, and sales methodology is required.
  • A strong understanding of field sales leadership and commercial operations is required.
  • Experience leading cross-functional initiatives and developing high-performing teams is required.
Responsibilities
  • Develop Biote's long-term Commercial Capability strategy.
  • Establish commercial competency models.
  • Build scalable learning architecture.
  • Develop capability roadmaps aligned with business growth.
  • Lead onboarding strategy.
  • Design commercial learning curriculum.
  • Develop product training programs.
  • Implement certification programs.
  • Create ongoing capability development.
  • Partner with Human Resources on first-line leader development.
  • Develop Regional Manager coaching capability.
  • Build Commercial Leadership curriculum in partnership with Human Resources.
  • Provide leadership for the Director of Commercial Talent Pipeline.
  • Directly lead the ATM program until the Director of Commercial Talent Pipeline is appointed and build a strong pipeline of future Territory Managers.
  • Develop future Territory Managers.
  • Build Emerging Leader programs.
  • Create internal promotion pathways.
  • Partner with Sales Leadership to improve commercial execution.
  • Improve coaching effectiveness.
  • Support product launches.
  • Improve field readiness and execution by establishing consistent field execution standards and translating commercial strategy into observable field behaviors, coaching practices, and performance expectations.
  • Partner closely with the SVP Sales, Area Sales Directors, Region Managers, Marketing, Commercial Operations, and Human Resources.
Desired Qualifications
  • An advanced degree is preferred.

Biote focuses on hormone optimization using clinically validated medical approaches to identify and treat imbalances in hormone production. It uses lab testing and medical assessment to pinpoint hormone deficiencies or excesses, then prescribes personalized treatment plans—often including bio-identical hormone therapy and related regimens—under medical supervision to restore balanced hormone levels. Biote differentiates itself through its emphasis on translating extensive scientific insight (80+ years of research) into validated protocols and continuing medical oversight, rather than generic supplements. The company’s goal is to help patients achieve balanced hormone levels and improve health outcomes by delivering scientifically grounded, physician-guided hormone optimization.

Company Size

201-500

Company Stage

IPO

Headquarters

Irving, Texas

Founded

2012

Get referred to Biote

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Biote resolved several legal matters in Q2 2026, reducing future SG&A drag.
  • Komal Bajaj became Chief Medical Officer on June 1, 2026, strengthening clinical credibility.
  • Asteria normalized inventory in August 2026, supporting second-half 2026 recovery and guidance rebound.

What critics are saying

  • The January 2026 Asteria recall cut Q2 2026 revenue 9.5% and margin.
  • Bret Christensen’s June 8, 2026 exit and Bob Peterson’s interim CEO role signal instability.
  • Biote’s SEC 10-K flags regulatory pressure on compounded hormones and Nasdaq delisting risk.

What makes Biote unique

  • Biote’s practitioner network and training model create sticky clinic relationships and repeat utilization.
  • Asteria Health gives Biote proprietary pellet manufacturing control, despite the January 2026 recall.
  • Biote pairs pellets with supplements, creating cross-sell revenue beyond procedures.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Paid Time Off

Company News

Hemingway Medical Spa
Jan 11th, 2025
Testosterone and Estradiol Pellet Therapy: Unlocking Wellness with Bioidentical Hormone Pellets

Hemingway Medical Spa Inc. partnered with Biote because they share its commitment to improving the quality of patients lives through a more natural and less pharmacologic approach.

Hampton Roads Orthopaedics Spine & Sports Medicine
Mar 1st, 2024
Transform Your Well-being with Bioidentical Hormone Replacement Therapy

Hampton Roads Orthopaedics and Sports Medicine has chosen Biote as its partner for hormone replacement therapy due to their proven track record and commitment to excellence.

Dallas Next
Jan 24th, 2024
Biote Acquires Asteria Health for $8.5M, Names New CFO

Irving-based Biote Corp. announced that it will acquire Asteria Health, a privately held manufacturer of compounded bioidentical hormones, in a deal valued at $8.5 million.

Business Wire
Jan 18th, 2024
Biote to Purchase Asteria Health

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hor

Read Magazine
Jan 12th, 2024
Biote Names Robert Peterson as Chief Financial Officer

biote Corp., a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024.